Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome - An open label pilot study

Journal of Clinical Biochemistry and Nutrition

Volumn 46, Issue 2, 2010, Pages 140-149

  Nakao, Atsunori ^a   Toyoda, Yoshiya ^a   Sharma, Prachi ^b   Evans, Malkanthi ^b   Guthrie, Najla ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b KGK Synergize Inc   (Canada)

Author keywords

Drinking water; Hydrogen; Magnesium; Metabolic syndrome; Oxidative stress

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; DRINKING WATER; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROGEN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TRIACYLGLYCEROL;

ADULT; ADVERSE OUTCOME; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CHEMICAL REACTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FLUID INTAKE; GLUCOSE BLOOD LEVEL; HEADACHE; HEARTBURN; HUMAN; LOOSE FECES; MALE; METABOLIC SYNDROME X; OPEN STUDY; OXIDATIVE STRESS; PATIENT SAFETY; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL;

EID: 77949869116     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.09-100     Document Type: Article

References (30)

1. Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., and Shimomura, I.: Increased oxidative stress in obesity and its impact on metabolic syndrome. J. Clin. Invest, 114, 1752-1761, 2004.
2. Holv̇oet, P., Lee, D.H., Steffes, M., Gross, M., and Jacobs, D.R.Jr.: Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA, 299, 2287-2293, 2008.
3. Ford, E.S., Giles, W.H., and Dietz, W.H.: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA, 287, 356-359, 2002.
4. Grundy, S.M., Brewer, H.B. Jr., Cleeman, J.I., Smith, S.C.Jr., and Lenfant, C.: Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 109, 433-438, 2004.
5. Dean, R.T., Fu, S., Stocker, R., and Davies, M.J.: Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J., 324, 1-18, 1997.
6. Halliwell, B., Gutteridge, J.M., and Cross, C.E.: Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med, 119, 598-620, 1992.
7. Ford, E.S., Mokdad, A.H., Giles, W.H., and Brown, D.W.: The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes, 52, 2346-2352, 2003.
8. Villeponteau, B., Cockrell, R., and Feng, J.: Nutraceutical interventions may delay aging and the age-related diseases. Exp. Gerontol, 35, 1405-1417, 2000.
9. Halliwell, B.: Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am. J. Med, 91, 14S-22S, 1991.
10. Ohsawa, I., Ishikawa, M., Takahashi, K., Watanabe, M., Nishimaki, K., Yamagata, K., Katsura, K., Katayama, Y., Asoh, S., and Ohta, S.: Hydrogen acts as a therapeutic anti-oxidant by selectively reducing cytotoxic oxygen radicals. Nat. Med., 13, 688-694, 2007.
11. Buchholz, B.M., Kaczorowski, D.J., Sugimoto, R., Yang, R., Wang, Y., Billiar, T.R., McCurry, K.R., Bauer, A.J., and Nakao, A.: Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am. J. Transplant., 8, 2015-2024, 2008.
12. N.A.S.A.: Safety Standard for Hydrogen and Hydrogen Systems. National Aeronautics and Space Administration, 2005.
13. Ohsawa, I., Nishimaki, K., Yamagata, K., Ishikawa, M., and Ohta, S.: Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem. Biophys. Res. Commun., 377, 1195-1198, 2008.
14. Nakashima-Kamimura, N., Mori, T., Ohsawa, I., Asoh, S., and Ohta, S.: Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer. Chemother. Pharmacol, 64, 753-761, 2009.
15. Sato, Y., Kajiyama, S., Amano, A., Kondo, Y., Sasaki, T., Handa, S., Takahashi, R., Fukui, M., Hasegawa, G., Nakamura, N., Fujinawa, H., Mori, T., Ohta, M., Obayashi, H., Maruyama, N., and Ishigami, A.: Hydrogen-rich pure water prevents superoxide formation in brain slices of vitamin C-depleted SMP30/GNL knockout mice. Biochem. Biophys. Res. Commun., 375, 346-350, 2008.
16. Cardinal, J.S., Zhan, J., Wang, Y., Sugimoto, R., Tsung, A., McCurry, K.R., Billiar, T.R., and Nakao, A.: Oral administration of hydrogen water prevents chronic allograft nephropathy in renal transplantation. Kidney Int., 2009, in press.
17. Kajiyama, S., Hasegawa, G., Asano, M., Hosoda, H., Fukui, M., Nakamura, N., Kitawaki, J., Imai, S., Nakano, K., Ohta, M., Adachi, T., Obayashi, H., and Yoshikawa, T.: Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr. Res., 28, 137-143, 2008.
18. Yagi, K.: Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods. Mol. Biol., 108, 107-110, 1998.
19. Loft, S., Fischer-Nielsen, A., Jeding, I.B., Vistisen, K., and Poulsen, H.E.: 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative DNA damage. J. Toxicol. Environ. Health., 40, 391-404, 1993.
20. Kinnula, V.L. and Crapo, J.D.: Superoxide dismutases in the lung and human lung diseases. Am. J. Respir. Crit Care. Med., 167, 1600-1619, 2003.
21. Noor, R., Mittal, S., and Iqbal, J.: Superoxide dismutaseapplications and relevance to human diseases. Med. Sci. Monit., 8, RA210-215, 2002.
22. Fukai, T., Folz, R.J., Landmesser, U., and Harrison, D.G: Extracellular superoxide dismutase and cardiovascular disease. Cardiovasc. Res., 55, 239-249, 2002.
23. Batiste, M.C. and Schaefer, E.J.: Diagnosis and management of lipoprotein abnormalities. Nutr. Clin. Care., 5, 115-123, 2002.
24. Whitfield, J.B.: Gamma glutamyl transferase. Crit. Rev. Clin. Lab. Sci., 38, 263-355, 2001.
25. Lee, D.H., Blomhoff, R., and Jacobs, D.R.Jr.: Is serum gamma glutamyltransferase a marker of oxidative stress? Free Radie. Res., 38, 535-539, 2004.
26. Schwertner, H.A., Jackson, W.G., and Tolan, G.: Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin. Chem., 40, 18-23, 1994.
27. Madhavan, M., Wattigney, W.A., Srinivasan, S.R., and Berenson, G.S.: Serum bilirubin distribution and its relation to cardiovascular risk in children and young adults. Atherosclerosis, 131, 107-113, 1997.
28. Tenhunen, R., Marver, H.S., and Schmid, R.: The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc. Natl. Acad. Sci. U.S.A., 61, 748-755, 1968.
29. Otterbein, L.E., Soares, M.P., Yamashita, K., and Bach, F.H.: Heme oxygenase-1: unleashing the protective properties of heme. Trends. Immunol., 24, 449-455, 2003.
30. Dilsiz, N., Olcucu, A., Cay, M., Naziroglu, M., and Cobanoglu, D.: Protective effects of selenium, vitamin C and vitamin E against oxidative stress of cigarette smoke in rats. Cell Biochem. Funct., 17, 1-7, 1999.